Modulation of the Serotonergic Receptosome in the Treatment of Anxiety and Depression: A Narrative Review of the Experimental Evidence
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Modulation of the Serotonergic Receptosome in the Treatment of Anxiety and Depression: A Narrative Review of the Experimental Evidence
Authors
Keywords
-
Journal
Pharmaceuticals
Volume 14, Issue 2, Pages 148
Publisher
MDPI AG
Online
2021-02-13
DOI
10.3390/ph14020148
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Constitutive activity of 5-HT receptors: Factual analysis
- (2020) Philippe De Deurwaerdère et al. NEUROPHARMACOLOGY
- Cannabidiol attenuates behavioral changes in a rodent model of schizophrenia through 5-HT1A, but not CB1 and CB2 receptors
- (2020) Naielly Rodrigues da Silva et al. PHARMACOLOGICAL RESEARCH
- Acute 5-HT2C Receptor Antagonist SB-242084 Treatment Affects EEG Gamma Band Activity Similarly to Chronic Escitalopram
- (2020) Noémi Papp et al. Frontiers in Pharmacology
- 5-HT1A and α2 adrenergic receptor levels are associated with high anxiety-like patterns and impulsivity in selectively bred Long Evans rats
- (2020) Tim Niedzielak et al. BEHAVIOURAL BRAIN RESEARCH
- Prenatal stress‐related alterations in synaptic transmission and 5‐HT 7 receptor‐mediated effects in the rat dorsal raphe nucleus are ameliorated by the 5‐HT 7 receptor antagonist SB 269970
- (2020) Joanna Sowa et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- Anxiolytic and antidepressant effects of Ziziphus mucronata hydromethanolic extract in male rats exposed to unpredictable chronic mild stress: Possible mechanisms of actions
- (2020) Wado Eglantine Keugong et al. JOURNAL OF ETHNOPHARMACOLOGY
- Translating the promise of 5HT4 receptor agonists for the treatment of depression
- (2020) Susannah E Murphy et al. PSYCHOLOGICAL MEDICINE
- Anxiolytic activity of Coriandrum sativum seeds aqueous extract on chronic restraint stressed mice and effect on brain neurotransmitters
- (2020) Swati Sahoo et al. Journal of Functional Foods
- Lasmiditan mechanism of action – review of a selective 5-HT1F agonist
- (2020) David B. Clemow et al. JOURNAL OF HEADACHE AND PAIN
- Central 5-HT receptors and their function; present and future
- (2020) Trevor Sharp et al. NEUROPHARMACOLOGY
- Untargeted Metabolomics Reveals Anaerobic Glycolysis as a Novel Target of the Hepatotoxic Antidepressant Nefazodone
- (2020) Evelin Krajnc et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Leptin Increases Expression of 5-HT2B Receptors in Astrocytes Thus Enhancing Action of Fluoxetine on the Depressive Behavior Induced by Sleep Deprivation
- (2019) Xiaowei Li et al. Frontiers in Psychiatry
- Emergence of 5-HT5A signaling in parvalbumin neurons mediates delayed antidepressant action
- (2019) Yotam Sagi et al. MOLECULAR PSYCHIATRY
- Social isolation rearing-induced anxiety and response to agomelatine in male and female rats: Role of corticosterone, oxytocin, and vasopressin
- (2019) Brian H Harvey et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Anticonvulsant, sedative, anxiolytic and antidepressant activities of the essential oil of Annona vepretorum in mice: Involvement of GABAergic and serotonergic systems
- (2019) Tâmara Coimbra Diniz et al. BIOMEDICINE & PHARMACOTHERAPY
- Sex-dependent modulation of anxiety and fear by 5-HT1A receptors in the bed nucleus of the stria terminalis
- (2019) Catherine Marcinkiewcz et al. ACS Chemical Neuroscience
- Molecular aspects of depression: A review from neurobiology to treatment
- (2019) Gustavo Roberto Villas Boas et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Anxiolytic effect of a novel 9,10-dihydrophenanthrene, juncuenin H, is associated with metabolic changes in cortical serotonin/dopamine levels in mice
- (2019) Lu Sun et al. FITOTERAPIA
- Altered Connectivity in Depression: GABA and Glutamate Neurotransmitter Deficits and Reversal by Novel Treatments
- (2019) Ronald S. Duman et al. NEURON
- Role of 5-HT2C receptors of the dorsal hippocampus in the modulation of anxiety- and panic-related defensive responses in rats
- (2019) Ana Beatriz Sant’Ana et al. NEUROPHARMACOLOGY
- Buspirone for the treatment of anxiety-related symptoms in Angelman syndrome
- (2019) Kayla Balaj et al. PSYCHIATRIC GENETICS
- Targeting the 5-HT2C Receptor in Biological Context and the Current State of 5-HT2C Receptor Ligand Development
- (2019) Eric A. Wold et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Intravenous vortioxetine to accelerate onset of effect in major depressive disorder
- (2019) Eduard Vieta et al. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
- 5-HT3 Receptor Antagonists in Neurologic and Neuropsychiatric Disorders: The Iceberg Still Lies beneath the Surface
- (2019) Gohar Fakhfouri et al. PHARMACOLOGICAL REVIEWS
- Rapid anxiolytic effects of RS67333, a serotonin type 4 receptor agonist, and diazepam, a benzodiazepine, are mediated by projections from the prefrontal cortex to the dorsal raphe nucleus
- (2019) Charlene Faye et al. BIOLOGICAL PSYCHIATRY
- Targeting Serotonin1A Receptors for Treating Chronic Pain and Depression
- (2019) Darakhshan Jabeen Haleem Current Neuropharmacology
- Brexpiprazole as an augmentation agent to antidepressants in treatment resistant major depressive disorder
- (2019) Danielle S. Cha et al. Expert Review of Neurotherapeutics
- 5-HT1A receptor, 5-HT2A receptor and serotonin transporter binding in the human auditory cortex in depression
- (2019) Louisa J. Steinberg et al. JOURNAL OF PSYCHIATRY & NEUROSCIENCE
- Anxiolytic activities of Matcha tea powder, extracts, and fractions in mice: Contribution of dopamine D1 receptor- and serotonin 5-HT1A receptor-mediated mechanisms
- (2019) Yuki Kurauchi et al. Journal of Functional Foods
- The blockade of the serotoninergic receptors 5-HT5A, 5-HT6 and 5-HT7 in the basolateral amygdala, but not in the hippocampus facilitate the extinction of fear memory
- (2019) Eduardo Silva de Assis Brasil et al. BEHAVIOURAL BRAIN RESEARCH
- Anxiolytic- and antidepressant-like activities of hydroethanol leaf extract of Newbouldia laevis (P.Beauv.) Seem. (Bignoniaceae) in mice
- (2019) Akanji A. Murtala et al. JOURNAL OF ETHNOPHARMACOLOGY
- Prophylactic efficacy of 5-HT4R agonists against stress
- (2019) Briana K. Chen et al. NEUROPSYCHOPHARMACOLOGY
- Antidepressant effect of the interaction of fluoxetine with granisetron
- (2019) Mihnea Costescu et al. Experimental and Therapeutic Medicine
- Dentate nNOS accounts for stress‐induced 5‐HT 1A receptor deficiency: Implication in anxiety behaviors
- (2019) Li‐Juan Zhu et al. CNS Neuroscience & Therapeutics
- Discovery of a Synergistic Inhibitor of cAMP-Response Element Binding Protein (CREB)-Mediated Gene Transcription with 666-15
- (2019) Fuchun Xie et al. JOURNAL OF MEDICINAL CHEMISTRY
- Anxiety during alcohol withdrawal involves 5-HT2C receptors and M-channels in the lateral habenula
- (2019) Rao Fu et al. NEUROPHARMACOLOGY
- Preclinical characterization of ACH-000029, a novel anxiolytic compound acting on serotonergic and alpha-adrenergic receptors
- (2019) Hatylas Azevedo et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Activation of 5-HT 1B receptors in the Lateral Habenula attenuates the anxiogenic effects of cocaine
- (2018) Adam K. Klein et al. BEHAVIOURAL BRAIN RESEARCH
- The Pharmacology, Pharmacokinetics, Efficacy, and Adverse Events Associated With Kava
- (2018) C. Michael White JOURNAL OF CLINICAL PHARMACOLOGY
- Role of the hippocampal 5-HT1A receptor-mediated cAMP/PKA signalling pathway in sevoflurane-induced cognitivedysfunction in aged rats
- (2018) Yi Qiu et al. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
- Tropisetron attenuates lipopolysaccharide induced neuroinflammation by inhibiting NF-κB and SP/NK1R signaling pathway
- (2018) Yan YU et al. JOURNAL OF NEUROIMMUNOLOGY
- Anxiolytic-like effects of paeoniflorin in an animal model of post traumatic stress disorder
- (2018) Zhi-Kun Qiu et al. METABOLIC BRAIN DISEASE
- Involvement of prelimbic 5-HT7 receptors in the regulation of anxiety-like behaviors in hemiparkinsonian rats
- (2018) Cheng Xue Du et al. NEUROLOGICAL RESEARCH
- The anxiolytic effects of cannabidiol in chronically stressed mice are mediated by the endocannabinoid system: Role of neurogenesis and dendritic remodeling
- (2018) Manoela V. Fogaça et al. NEUROPHARMACOLOGY
- Herbal medicines in the treatment of psychiatric disorders: 10-year updated review
- (2018) Jerome Sarris PHYTOTHERAPY RESEARCH
- Spinal 5-HT1AR contributes to the analgesia of acupoint catgut embedding by inhibiting phosphorylation of the NMDA receptor GluN1 subunit in CFA-induced inflammatory pain in rats
- (2018) Wen-Qiang Cui et al. JOURNAL OF PAIN
- Serotonin receptors in depression and anxiety: Insights from animal studies
- (2018) Elżbieta Żmudzka et al. LIFE SCIENCES
- Chronic methamphetamine self-administration dysregulates 5-HT2A and mGlu2 receptor expression in the rat prefrontal and perirhinal cortex: Comparison to chronic phencyclidine and MK-801
- (2018) Peter U. Hámor et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- The 5-HT1A receptor: Signaling to behavior
- (2018) Paul R. Albert et al. BIOCHIMIE
- Evaluation of vilazodone for the treatment of depressive and anxiety disorders
- (2018) Mirella Stuivenga et al. EXPERT OPINION ON PHARMACOTHERAPY
- Loss of adult 5-HT1A autoreceptors results in a paradoxical anxiogenic response to antidepressant treatment
- (2018) Valérie Turcotte-Cardin et al. JOURNAL OF NEUROSCIENCE
- Mirtazapine added to SSRIs or SNRIs for treatment resistant depression in primary care: phase III randomised placebo controlled trial (MIR)
- (2018) David S Kessler et al. BMJ-British Medical Journal
- Agomelatine for the treatment of generalized anxiety disorder
- (2017) Massimiliano Buoli et al. EXPERT OPINION ON PHARMACOTHERAPY
- Clinical use of Hypericum perforatum (St John's wort) in depression: A meta-analysis
- (2017) Qin Xiang Ng et al. JOURNAL OF AFFECTIVE DISORDERS
- Maerua angolensis stem bark extract reverses anxiety and related behaviours in zebrafish—Involvement of GABAergic and 5-HT systems
- (2017) Charles Kwaku Benneh et al. JOURNAL OF ETHNOPHARMACOLOGY
- Anxiolytic- and antidepressant-like effects of an aqueous extract of Tanacetum parthenium L. Schultz-Bip (Asteraceae) in mice
- (2017) Jorge Cárdenas et al. JOURNAL OF ETHNOPHARMACOLOGY
- Serotonin 5-HT7 receptor increases the density of dendritic spines and facilitates synaptogenesis in forebrain neurons
- (2017) Luisa Speranza et al. JOURNAL OF NEUROCHEMISTRY
- Dual effect of serotonin on the dendritic growth of cultured hippocampal neurons: Involvement of 5-HT 1A and 5-HT 7 receptors
- (2017) P.S. Rojas et al. MOLECULAR AND CELLULAR NEUROSCIENCE
- Single Administration of HBK-15—a Triple 5-HT1A, 5-HT7, and 5-HT3 Receptor Antagonist—Reverses Depressive-Like Behaviors in Mouse Model of Depression Induced by Corticosterone
- (2017) Karolina Pytka et al. MOLECULAR NEUROBIOLOGY
- CK2 regulates 5-HT4 receptor signaling and modulates depressive-like behavior
- (2017) J Castello et al. MOLECULAR PSYCHIATRY
- Serotonin inputs to the dorsal BNST modulate anxiety in a 5-HT1A receptor-dependent manner
- (2017) A L Garcia-Garcia et al. MOLECULAR PSYCHIATRY
- A short history of the 5-HT2C receptor: from the choroid plexus to depression, obesity and addiction treatment
- (2017) Jose M. Palacios et al. PSYCHOPHARMACOLOGY
- Novel 5-HT3 receptor antagonist QCM-4 attenuates depressive-like phenotype associated with obesity in high-fat-diet-fed mice
- (2017) Yeshwant Kurhe et al. PSYCHOPHARMACOLOGY
- BDNF val66met Polymorphism Impairs Hippocampal Long-Term Depression by Down-Regulation of 5-HT3 Receptors
- (2017) Rui Hao et al. Frontiers in Cellular Neuroscience
- Role of tandospirone, a 5-HT1A receptor partial agonist, in the treatment of central nervous system disorders and the underlying mechanisms
- (2017) Xuefei Huang et al. Oncotarget
- miR-16 and miR-103 impact 5-HT4 receptor signalling and correlate with symptom profile in irritable bowel syndrome
- (2017) Carolin Wohlfarth et al. Scientific Reports
- Ritanserin-sensitive receptors modulate the prosocial and the anxiolytic effect of MDMA derivatives, DOB and PMA, in zebrafish
- (2016) Luisa Ponzoni et al. BEHAVIOURAL BRAIN RESEARCH
- 5-HT2A and mGlu2/3 receptor interactions
- (2016) Lena Wischhof et al. BEHAVIOURAL PHARMACOLOGY
- Prebiotic administration normalizes lipopolysaccharide (LPS)-induced anxiety and cortical 5-HT2A receptor and IL1-β levels in male mice
- (2016) Helene M. Savignac et al. BRAIN BEHAVIOR AND IMMUNITY
- Attenuation of oxidative and nitrosative stress in cortical area associates with antidepressant-like effects of tropisetron in male mice following social isolation stress
- (2016) Arya Haj-Mirzaian et al. BRAIN RESEARCH BULLETIN
- Adjunctive Brexpiprazole: A Review in Major Depressive Disorder
- (2016) Kate McKeage CNS DRUGS
- Mechanism of action of brexpiprazole: comparison with aripiprazole
- (2016) Stephen M. Stahl CNS SPECTRUMS
- Les bases de pharmacologie fondamentale du système sérotoninergique : application à la réponse antidépressive
- (2016) D.J. David et al. ENCEPHALE-REVUE DE PSYCHIATRIE CLINIQUE BIOLOGIQUE ET THERAPEUTIQUE
- Towards new 5-HT 7 antagonists among arylsulfonamide derivatives of (aryloxy)ethyl-alkyl amines: Multiobjective based design, synthesis, and antidepressant and anxiolytic properties
- (2016) Vittorio Canale et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Serotonin 5-HT1Breceptor-mediated calcium influx-independent presynaptic inhibition of GABA release onto rat basal forebrain cholinergic neurons
- (2016) Takuma Nishijo et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- Neurochemical factors associated with the antidepressant-like effect of flavonoid chrysin in chronically stressed mice
- (2016) Carlos Borges Filho et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Mice lacking the serotonin 5-HT 2B receptor as an animal model of resistance to selective serotonin reuptake inhibitors antidepressants
- (2016) Silvina Laura Diaz et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- New advances in the treatment of generalized anxiety disorder: the multimodal antidepressant vortioxetine
- (2016) Laura Orsolini et al. Expert Review of Neurotherapeutics
- Chronic Vortioxetine Treatment Reduces Exaggerated Expression of Conditioned Fear Memory and Restores Active Coping Behavior in Chronically Stressed Rats
- (2016) Lauren Hatherall et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Involvement of monoaminergic systems in anxiolytic and antidepressive activities of the standardized extract of Cocos nucifera L.
- (2016) Eliane Brito Cortez Lima et al. Journal of Natural Medicines
- ADN-1184, a monoaminergic ligand with 5-HT6/7 receptor antagonist action, exhibits activity in animal models of anxiety
- (2016) Anna Partyka et al. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
- Study of a mechanism responsible for potential antidepressant activity of EMD 386088, a 5-HT6 partial agonist in rats
- (2016) Magdalena Jastrzębska-Więsek et al. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
- Orbitofrontal cortex 5-HT2A receptor mediates chronic stress-induced depressive-like behaviors and alterations of spine density and Kalirin7
- (2016) Chang Xu et al. NEUROPHARMACOLOGY
- Activation and blockade of prelimbic 5-HT 6 receptors produce different effects on depressive-like behaviors in unilateral 6-hydroxydopamine-induced Parkinson's rats
- (2016) Yu-Ming Zhang et al. NEUROPHARMACOLOGY
- Involvement of 5-HT 3 receptors in the action of vortioxetine in rat brain: Focus on glutamatergic and GABAergic neurotransmission
- (2016) Maurizio S. Riga et al. NEUROPHARMACOLOGY
- The absence of 5-HT4 receptors modulates depression- and anxiety-like responses and influences the response of fluoxetine in olfactory bulbectomised mice: Adaptive changes in hippocampal neuroplasticity markers and 5-HT1A autoreceptor
- (2016) J. Amigó et al. NEUROPHARMACOLOGY
- 5-HT1A receptors of the rat dorsal raphe lateral wings and dorsomedial subnuclei differentially control anxiety- and panic-related defensive responses
- (2016) Ailton Spiacci et al. NEUROPHARMACOLOGY
- A Lack of Serotonin 1B Autoreceptors Results in Decreased Anxiety and Depression-Related Behaviors
- (2016) Katherine M Nautiyal et al. NEUROPSYCHOPHARMACOLOGY
- Duloxetine and 8-OH-DPAT, but not fluoxetine, reduce depression-like behaviour in an animal model of chronic neuropathic pain
- (2016) Bing Hu et al. NEUROSCIENCE LETTERS
- Gi-protein–coupled 5-HT1B/D receptor agonist sumatriptan induces type I hyperalgesic priming
- (2016) Dioneia Araldi et al. PAIN
- The anxiolytic effect of essential oil of Cananga odorata exposure on mice and determination of its major active constituents
- (2016) Nan Zhang et al. PHYTOMEDICINE
- 5-HT2C receptors in psychiatric disorders: A review
- (2016) A. Chagraoui et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- New advances in the treatment of generalized anxiety disorder: the multimodal antidepressant vortioxetine
- (2016) Laura Orsolini et al. Expert Review of Neurotherapeutics
- Piperazine Analogs of Naphthyridine-3-carboxamides and Indole-2-carboxamides: Novel 5-HT3Receptor Antagonists with Antidepressant-Like Activity
- (2015) Arghya K. Dhar et al. ARCHIV DER PHARMAZIE
- Tropisetron attenuated the anxiogenic effects of social isolation by modulating nitrergic system and mitochondrial function
- (2015) Shayan Amiri et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- Antidepressant-like effect of Hoodia gordonii in a forced swimming test in mice: evidence for involvement of the monoaminergic system
- (2015) M.C.O. Citó et al. BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH
- S100B interacts with the serotonin 5-HT7 receptor to regulate a depressive-like behavior
- (2015) Nikolas Stroth et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Evaluation of the Anxiolytic and Antidepressant Activities of the Aqueous Extract fromCamellia euphlebiaMerr. ex Sealy in Mice
- (2015) Dongye He et al. Evidence-based Complementary and Alternative Medicine
- Functional Selectivity and Antidepressant Activity of Serotonin 1A Receptor Ligands
- (2015) Zdzisław Chilmonczyk et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Convergence of Melatonin and Serotonin (5-HT) Signaling at MT2/5-HT2CReceptor Heteromers
- (2015) Maud Kamal et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Antidepressant-like activity of Tagetes lucida Cav. is mediated by 5-HT1A and 5-HT2A receptors
- (2015) H. Bonilla-Jaime et al. Journal of Natural Medicines
- Antidepressant-like activity of EMD 386088, a 5-HT6 receptor partial agonist, following systemic acute and chronic administration to rats
- (2015) Magdalena Jastrzębska-Więsek et al. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
- Serotonin-2C antagonism augments the effect of citalopram on serotonin and dopamine levels in the ventral tegmental area and nucleus accumbens
- (2015) Anniek K.D. Visser et al. NEUROCHEMISTRY INTERNATIONAL
- Activation of 5-HT2a receptors in the basolateral amygdala promotes defeat-induced anxiety and the acquisition of conditioned defeat in Syrian hamsters
- (2015) Catherine T. Clinard et al. NEUROPHARMACOLOGY
- Ondansetron attenuates co-morbid depression and anxiety associated with obesity by inhibiting the biochemical alterations and improving serotonergic neurotransmission
- (2015) Yeshwant Kurhe et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- A 5-HT3 receptor antagonist potentiates the behavioral, neurochemical and electrophysiological actions of an SSRI antidepressant
- (2015) C. Bétry et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Decrease of gene expression of astrocytic 5-HT2B receptors parallels development of depressive phenotype in a mouse model of Parkinson’s disease
- (2015) Xique Zhang et al. Frontiers in Cellular Neuroscience
- Chronic SSRI stimulation of astrocytic 5-HT2B receptors change multiple gene expressions/editings and metabolism of glutamate, glucose and glycogen: a potential paradigm shift
- (2015) Leif Hertz et al. Frontiers in Behavioral Neuroscience
- Central serotonin-2A (5-HT2A) receptor dysfunction in depression and epilepsy: the missing link?
- (2015) Bruno P. Guiard et al. Frontiers in Pharmacology
- Pharmacological Characterization of 5-HT1A Autoreceptor-Coupled GIRK Channels in Rat Dorsal Raphe 5-HT Neurons
- (2015) Alberto Montalbano et al. PLoS One
- Antidepressant-like effects of a novel 5-HT3 receptor antagonist 6z in acute and chronic murine models of depression
- (2014) Deepali Gupta et al. ACTA PHARMACOLOGICA SINICA
- Fluoxetine and all other SSRIs are 5-HT2B Agonists - Importance for their Therapeutic Effects
- (2014) Liang Peng et al. Current Neuropharmacology
- Antidepressant and anti-anxiety like effects of 4i (N-(3-chloro-2-methylphenyl) quinoxalin-2-carboxamide), a novel 5-HT3 receptor antagonist in acute and chronic neurobehavioral rodent models
- (2014) Deepali Gupta et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Ondansetron, a 5HT3 receptor antagonist reverses depression and anxiety-like behavior in streptozotocin-induced diabetic mice: Possible implication of serotonergic system
- (2014) Deepali Gupta et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Anxiolytic-like effects observed in rats exposed to the elevated zero-maze following treatment with 5-HT2/5-HT3/5-HT4 ligands
- (2014) Rob Bell et al. Scientific Reports
- The serotonin receptor 7 and the structural plasticity of brain circuits
- (2014) Floriana Volpicelli et al. Frontiers in Behavioral Neuroscience
- Cellular mechanisms of the 5-HT7receptor-mediated signaling
- (2014) Daria Guseva et al. Frontiers in Behavioral Neuroscience
- How much do we know about the coupling of G-proteins to serotonin receptors?
- (2014) Matteo Giulietti et al. Molecular Brain
- Diversity and Bias through Receptor–Receptor Interactions in GPCR Heteroreceptor Complexes. Focus on Examples from Dopamine D2 Receptor Heteromerization
- (2014) Kjell Fuxe et al. Frontiers in Endocrinology
- Rapid Anxiolytic Effects of a 5-HT4 Receptor Agonist Are Mediated by a Neurogenesis-Independent Mechanism
- (2013) Indira Mendez-David et al. NEUROPSYCHOPHARMACOLOGY
- Effect of 5-HT5A antagonists in animal models of schizophrenia, anxiety and depression
- (2012) Ferenc Kassai et al. BEHAVIOURAL PHARMACOLOGY
- 5-HT6receptor recruitment of mTOR as a mechanism for perturbed cognition in schizophrenia
- (2012) Julie Meffre et al. EMBO Molecular Medicine
- A preliminary open trial of nefazodone added to mood stabilizers for bipolar depression
- (2012) Joseph F. Goldberg JOURNAL OF AFFECTIVE DISORDERS
- The Native Serotonin 5-HT5A Receptor: Electrophysiological Characterization in Rodent Cortex and 5-HT1A-Mediated Compensatory Plasticity in the Knock-Out Mouse
- (2012) N. M. Goodfellow et al. JOURNAL OF NEUROSCIENCE
- Modulation of antipsychotic-induced extrapyramidal side effects by medications for mood disorders
- (2012) Ayaka Tatara et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Facilitation of fear extinction by the 5-HT1Areceptor agonist tandospirone: Possible involvement of dopaminergic modulation
- (2012) Yasuhiro Saito et al. SYNAPSE
- Modulation of neuroplasticity pathways and antidepressant-like behavioural responses following the short-term (3 and 7 days) administration of the 5-HT4 receptor agonist RS67333
- (2011) Jesús Pascual-Brazo et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- The 5-HT6 receptor agonist EMD 386088 produces antidepressant and anxiolytic effects in rats after intrahippocampal administration
- (2011) Agnieszka Nikiforuk et al. PSYCHOPHARMACOLOGY
- Glycogen Synthase Kinase-3 is an Intermediate Modulator of Serotonin Neurotransmission
- (2011) Abigail M. Polter et al. Frontiers in Molecular Neuroscience
- 5-HT2B receptors are expressed on astrocytes from brain and in culture and are a chronic target for all five conventional ‘serotonin-specific reuptake inhibitors’
- (2010) Shiquen Zhang et al. Neuron Glia Biology
- Selective Serotonin Reuptake Inhibitors Potentiate the Rapid Antidepressant-Like Effects of Serotonin4 Receptor Agonists in the Rat
- (2010) Guillaume Lucas et al. PLoS One
- Antidepressant and anxiolytic effects of selective 5-HT6 receptor agonists in rats
- (2010) Gregory V. Carr et al. PSYCHOPHARMACOLOGY
- Evaluation of the Brain 5-HT2A Receptor Binding Index in Dogs with Anxiety Disorders, Measured with 123I-5I-R91150 and SPECT
- (2009) S. T. Vermeire et al. JOURNAL OF NUCLEAR MEDICINE
- Serotoninergic mechanisms in the treatment of obsessive–compulsive disorder
- (2008) Andrew W. Goddard et al. DRUG DISCOVERY TODAY
- S32006, a novel 5-HT2C receptor antagonist displaying broad-based antidepressant and anxiolytic properties in rodent models
- (2008) Anne Dekeyne et al. PSYCHOPHARMACOLOGY
- 5-HT2 receptor activation in the midbrain periaqueductal grey (PAG) reduces anxiety-like behaviour in mice
- (2007) Vanessa Nunes-de-Souza et al. BEHAVIOURAL BRAIN RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started